Motivations, influences and intentions to participate in NHS Cervical Screening
NHS England · awarded 17 July 2025 · delivered in England
Who
| Buyer | NHS England Leeds |
|---|---|
| Supplier |
Solutions Strategy Research Facilitation Ltd |
| Category | services |
| Classification | Health services CPV 85100000 |
| Notice published | 2 September 2025 |
What it is for
NHS England (NHSE) aims to understand motivations, influences and intentions to accept or decline their first NHS Cervical Screening invitation with a solution focused approach for women and people with a cervix from minority ethnic groups, and/or living in deprived areas (IMD 1-3) as per CORE20PLUS communities. The project will take a mixed method approach and is divided into three parts: Part 1: Reviewing of existing evidence and analysis Part 2: Conduct an Insight piece with the priority groups Part 3: Provide an Insight Report and Develop and deliver a webinar.
Read the original award notice on Contracts Finder →
Other contracts from this buyer
1269 awards on file, worth £50.2bn.
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 4 Mar 2026 | New Hospital Programme - Hospital 2.0 Alliance (H2A) FrameworkEngland | NHS England | Willmott Dixon Construction Limited +9 | £37.0bn |
| 24 Mar 2025 | NHS Framework Agreement for Branded Medicines - Proprietary Category TenderEast Midlands | NHS England | CSL Behring UK Ltd +71 | £1.2bn |
| 1 Jul 2025 | NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 | NHS England | Biogen +20 | £986.3m |
| 19 Dec 2024 | NHS Framework Agreement for Human Albumin & Normal and Anti-D ImmunoglobulinScotland | NHS England | CSL Behring UK Ltd +5 | £905.2m |
| 31 May 2024 | NHS Framework - Blood Disorders including Haemophilia A and B - July 2024East Midlands | NHS England | Pfizer Ltd +8 | £765.0m |
Everything NHS England has awarded →
Other contracts won by this supplier
5 awards on file, worth £500.5m.
Everything Solutions Strategy Research Facilitation Ltd has won →